Ke Xu

Ms. Ke Xu

University of Florida
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
AAAngelica Ahrens
Angelica Ahrens
TCTyler Culpepper
Tyler Culpepper
BSBrittany Saldivar
Brittany Saldivar
Stephen AntonStephen Anton
Stephen Anton
SSScott Stoll
Scott Stoll
MAMonica Aggarwal
Monica Aggarwal
Cardiovascular disease (CVD) prevalence remains elevated globally. We have previously shown that a one-week lifestyle “immersion program” leads to clinical improvements and sustained improvements in quality of life in moderate to high atherosclerotic CVD (ASCVD) risk individuals. In a subsequent year of this similarly modeled immersion program, we again collected markers of cardiovascular health and, additionally, evaluated intestinal microbiome composition. ASCVD risk volunteers (n = 73) completed the one-week “immersion program” involving nutrition (100% plant-based foods), stress management education, and exercise. Anthropometric measurements and CVD risk factors were compared at baseline and post intervention. A subgroup (n = 22) provided stool, which we analyzed with 16S rRNA sequencing. We assessed abundance changes within-person, correlated the abundance shifts with clinical changes, and inferred functional pathways using PICRUSt. Reductions in blood pressure, total cholesterol, and triglycerides, were observed without reduction in weight. Significant increases in butyrate producers were detected, including Lachnospiraceae and Oscillospirales. Within-person, significant shifts in relative abundance (RA) occurred, e.g., increased Lachnospiraceae (+58.8% RA, p = 0.0002), Ruminococcaceae (+82.1%, p = 0.0003), Faecalibacterium prausnitzii (+54.5%, p = 0.002), and diversification and richness. Microbiota changes significantly correlated with body mass index (BMI), blood pressure (BP), cholesterol, high-sensitivity C-reactive protein (hsCRP), glucose, and trimethylamine N-oxide (TMAO) changes. Pairwise decreases were inferred in microbial genes corresponding to cancer, metabolic disease, and amino acid metabolism. This brief lifestyle-based intervention improved lipids and BP and enhanced known butyrate producers, without significant weight loss. These results demonstrate a promising non-pharmacological preventative strategy for improving cardiovascular health.

12 May 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
CECarmella Evans-Molina
Carmella Evans-Molina
YPYasminye D. Pettway
Yasminye D. Pettway
DSDiane C. Saunders
Diane C. Saunders
SSSeth A. Sharp
Seth A. Sharp
TBThomas Sr. Bate
Thomas Sr. Bate
MBMarcela Brissova
Marcela Brissova
Phenotyping and genotyping initiatives within the Integrated Islet Distribution Program (IIDP), the largest source of human islets for research in the U.S., provide standardized assessment of islet preparations distributed to researchers and enable the integration of multiple data types. Data from islets of the first 299 organ donors without diabetes analyzed using this pipeline highlights substantial heterogeneity in islet cell composition associated with hormone secretory traits, sex, reported race and ethnicity, genetically predicted ancestry, and genetic risk for type 2 diabetes (T2D). While α and β cell composition influenced insulin and glucagon secretory traits, the abundance of δ cells showed the strongest association with insulin secretion and was also associated with the genetic risk score (GRS) for T2D. These findings have important implications for understanding mechanisms underlying diabetes heterogeneity and islet dysfunction and may provide insight into strategies for personalized medicine and β cell replacement therapy.

29 August 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
Dominick LemasDominick Lemas
Dominick Lemas
Xinsong DuXinsong Du
Xinsong Du
Bethany Dado-SennBethany Dado-Senn
Bethany Dado-Senn
KXKe Xu
Ke Xu
ADAmanda Dobrowolski
Amanda Dobrowolski
Timothy GarrettTimothy Garrett
Timothy Garrett
Epidemiological data demonstrate that bovine whole milk is often substituted for human milk during the first 12 months of life and may be associated with adverse infant outcomes. The objective of this study is to interrogate the human and bovine milk metabolome at 2 weeks of life to identify unique metabolites that may impact infant health outcomes. Human milk (n = 10) was collected at 2 weeks postpartum from normal-weight mothers (pre-pregnant BMI < 25 kg/m2) that vaginally delivered term infants and were exclusively breastfeeding their infant for at least 2 months. Similarly, bovine milk (n = 10) was collected 2 weeks postpartum from normal-weight primiparous Holstein dairy cows. Untargeted data were acquired on all milk samples using high-resolution liquid chromatography–high-resolution tandem mass spectrometry (HR LC-MS/MS). MS data pre-processing from feature calling to metabolite annotation was performed using MS-DIAL and MS-FLO. Our results revealed that more than 80% of the milk metabolome is shared between human and bovine milk samples during early lactation. Unbiased analysis of identified metabolites revealed that nearly 80% of milk metabolites may contribute to microbial metabolism and microbe–host interactions. Collectively, these results highlight untargeted metabolomics as a potential strategy to identify unique and shared metabolites in bovine and human milk that may relate to and impact infant health outcomes.

8 September 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YTYasmeen Taha
Yasmeen Taha
JDJennifer Dungan
Jennifer Dungan
MWMichael Timothy Weaver
Michael Timothy Weaver
KXKe Xu
Ke Xu
EHEileen M. Handberg
Eileen M. Handberg
C. Noel Bairey MerzC. Noel Bairey Merz
C. Noel Bairey Merz
Identifying ischemic heart disease (IHD) in women based on symptoms is challenging. Women are more likely to endorse non-cardiac symptoms. More than 50% of women with suspected ischemia have no obstructive coronary disease (and thus, INOCA) and impaired outcomes during follow-up. We aimed to identify symptoms having predictive capacity for INOCA in women with clinical evidence of coronary ischemia. We included 916 women from the original WISE cohort (NCT 00000554) who had coronary angiography performed for suspected ischemia and completed a 65-item WISE symptom questionnaire. Sixty-two percent (n = 567) had suspected INOCA. Logistic regression models using a best subsets approach were examined to identify the best predictive model for INOCA based on Score χ2 and AICc. A 10-variable, best-fit model accurately predicted INOCA (AUC 0.72, 95% CI 0.68, 0.75). The model indicated that age ≤ 55 years, left side chest pain, chest discomfort, neck pain, and palpitations had independent, positive relationship (OR > 1) to INOCA (p < 0.001 to 0.008). An inverse relationship (OR < 1) was observed for impending doom, and pain in the jaw, left or bilateral arm, and right hand, interpreted as INOCA associated with the absence of these symptoms (p ≤ 0.001 to 0.023). Our best-fit model accurately predicted INOCA based on age and symptom presentation ~72% of the time. While the heterogeneity of symptom presentation limits the utility of this unvalidated 10-variable model, it has promise for consideration of symptom inclusion in future INOCA prediction risk modeling for women with evidence of symptomatic ischemia.

1 September 2025 in Kidney Research and Clinical Practice
Verified
Journal Article
Open access
PDF file
KXKe Xu
Ke Xu
HKHakmook Kang
Hakmook Kang
Nephrology research plays an important role in advancing our understanding of kidney disease and improving patient outcomes. However, the complexity of nephrology data and the application of advanced statistical methods present significant challenges. This review highlights key statistical considerations in nephrology research, focusing on common errors such as violations of statistical assumptions, multicollinearity, missing data, overfitting, and the integration of machine learning tools. It emphasizes the importance of applying appropriate statistical approaches to ensure the reliability of study findings. Additionally, the review underscores the need for transparency and reproducibility in nephrology research, particularly the importance of open access to data, code, and study protocols. By utilizing tools like R, RStudio, Git, and GitHub, researchers can integrate their code, results, and data into a transparent workflow, enhancing the reproducibility of their research. This review also presents a practical checklist for promoting reproducible research practices, which can help improve the quality, transparency, and reliability of nephrology studies. This review aims to contribute to the advancement of nephrology research and, ultimately, to support the long-term goal of improving patient care and outcomes.

29 June 2026 in Nature Communications
Verified
Journal Article
Open access
DSDiane C. Saunders
Diane C. Saunders
FFFan Feng
Fan Feng
AHAlexander L. Hopkirk
Alexander L. Hopkirk
KAKristie I. Aamodt
Kristie I. Aamodt
NHNathaniel Hart
Nathaniel Hart
MBMarcela Brissova
Marcela Brissova
Human endocrine cell differentiation and islet morphogenesis play critical roles in determining islet cell mass and function, but the events and timeline of these processes are incompletely defined. To better understand early human islet cell development and maturation, we collected 123 pediatric pancreata and mapped morphological and spatiotemporal changes from birth through the first ten years of life. Using quantitative analyses and a combination of complementary tissue imaging approaches, including confocal microscopy and whole-slide multiplex imaging, we developed an integrated model for endocrine cell formation and islet architecture, including endocrine cell type heterogeneity and abundance, endocrine cell proliferation, and islet vascularization and innervation. We also assessed insulin and glucagon secretory profiles in isolated islet preparations from pediatric donors aged 2 months to 10 years and found a temporal difference in the maturation of insulin secretion compared to glucagon secretion. This comprehensive summary of postnatal and pediatric pancreatic islet development provides a framework for future studies and for integrating emerging genetic and genomic data related to islet biology and diabetes risk.